Redosing study… [Study As­sess­ment]

posted by GSTATS Homepage – India, 2011-06-17 18:57 (5078 d 01:07 ago) – Posting: # 7152
Views: 10,680

Dear LB

❝ ❝ ❝ 1. The identified Volunteer shows totally opposite behavior then the main study?

❝ ❝ ❝ E.g.: In main study T/R ratio was lets say 1500% and in re-dosing study it becomes 15%. In that condition what can one do?? :angry:


I will say theoretically it is not possible and practically it is possible only when the subject was in specific condition (vomit, under stress or anything) for one product in pivotal study and under same condition for another product in re-dosing study which means poor conduct of study.

❝ But that is not the problem of formulation as all others (65 volunteer out of 66) gave normal results in the range of 80-125% TR ratio (with min of 34% and max of 244%) and only one was acting weird.


❝ If such is the case, even after reformulation same volunteer or someone of the same category :crying: could be there to kill your study!!


❝ Then What??


Even if in a re-dosing study, subject repeats its anomalous behavior then no one can save your study. OR In place of going for re-dosing study, one can do an investigation and give solid clinical justification for such an outlying behavior with "statistical outlier test" confirming the value as an outlier.

Regards,
GSTATS
www.gstatsolutions.com

Let Noble Thoughts come from Every Side: RIG VEDA

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,671 registered users;
110 visitors (0 registered, 110 guests [including 54 identified bots]).
Forum time: 20:04 CEST (Europe/Vienna)

If you shut your door to all errors
truth will be shut out.    Rabindranath Tagore

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5